Novel Method producing/selecting and humanizing Antibodies
Monoclonal antibodies specifically bind to target cells or proteins and are therefore used as cancer diagnostics as well as therapeutics. The production of antibodies is different and there are also distinct antibody libraries existing to select the most effective antibodies.
We here describe a new method for producing a highly diverse antibody library, where pro-teins/antibodies can be selected for specific ap-plications. A large and, compared from cell to cell, highly uniform number of antibodies is covalently attached to the surface of a eukaryotic cell. Using this technology, specific antibodies can be se-lected together with the presenting cell out of a high number of cells in a comparatively easy way. The technology can also be used humanizing a hybridoma cell line by enabling the homologous recombination of the constant domains of human immunoglobulins with the respective gene.
Further Information: PDF
DKFZ (German Cancer Research Center, Deutsches Krebsforschungszentrum)
Phone: +49-6221-42 2955
Contact
Dr. Ruth Herzog
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Novel genetic plant regeneration approach
…without the application of phytohormones. Researchers develop a novel plant regeneration approach by modulating the expression of genes that control plant cell differentiation. For ages now, plants have been the…
Roadmap to close the carbon cycle
A holistic approach to reach net-zero carbon emissions across the economy. A major approach to achieving net-zero carbon emissions relies on converting various parts of the economy, such as personal…
Cost-effective, high-capacity, and cyclable lithium-ion battery cathodes
Charge-recharge cycling of lithium-superrich iron oxide, a cost-effective and high-capacity cathode for new-generation lithium-ion batteries, can be greatly improved by doping with readily available mineral elements. The energy capacity and…
